Esperion

About:

Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.

Twitter/X: Esperion

Top Investors: Longitude Capital, Arboretum Ventures, Domain Associates, Asset Management Ventures (AMV), Alta Partners

Description:

Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on a new treatment approach called "HDL Therapy," which is based on the Company's understanding of high-density lipoprotein, or HDL, function.

Total Funding Amount:

$853M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

1998-01-01

Founders:

Roger S. Newton

Number of Employees:

101-250